Ascent Pharmaceuticals recalls
FDA enforcement reports naming Ascent Pharmaceuticals, Inc. as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Dec 15, 2021
- Dec 15, 2021Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, R…Drug · Ascent Pharmaceuticals, Inc.Product Mix-upClass II
- Nov 25, 2020Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx…Drug · Ascent Pharmaceuticals, Inc.Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.Class II
- Feb 7, 2018Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured fo…Drug · Ascent Pharmaceuticals, Inc.Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbolClass III